معرفی
Chenxu Zhu is a tenure-track Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences, with a joint appointment as a Core Faculty Member at the New York Genome Center. He holds affiliations with the Department of Physiology and Biophysics and the Institute for Computational Biomedicine.
- B.S. in Chemistry (2011), Wuhan University
- Ph.D. in Biochemistry and Molecular Biology (2017), Peking University
- Postdoctoral research at Ludwig Institute for Cancer Research & UC San Diego
Dr. Zhu develops cutting-edge single-cell multiomics technologies to investigate molecular networks governing cell fate specification and maintenance. His work focuses on integrating epigenomic analysis with transcriptomic profiling to unravel regulatory layers in cancer heterogeneity, DNA damage response, and neural system dynamics. Current projects span single-cell DNA damage analysis, epigenomic technology development, and cell differentiation dynamics.
His research bridges genomic technologies with disease mechanisms, particularly in cancer and neural systems. The lab specializes in multimodal single-cell tools to capture simultaneous epigenetic and transcriptional profiles from complex tissues.
Scientific Distinctions:
- NIH Director's New Innovator Award (2023)
- NIH Pathway to Independence Award (2020)
Dr. Zhu's lab at Weill Cornell Medicine combines computational biomedicine with experimental genomics to address fundamental questions about cellular regulation in health and disease contexts.
